(18)F-labelling of A-ring substituted 16alpha-fluoro-estradiols as potential radiopharmaceuticals for PET imaging

Steroids. 2009 Jan;74(1):42-50. doi: 10.1016/j.steroids.2008.09.006. Epub 2008 Sep 18.

Abstract

The 2-methoxy derivative of estradiol is currently in Phase II clinical trial as an anticancer agent while the 4-methyl derivative has been shown to interact with cytoplasmic and nuclear estrogen receptors in rat pituitary gland and hypothalamus. We hypothesize that the 16alpha-(18)F-analogs of these estrogens could be suitable radiotracers to evaluate action mechanisms of the parent compounds. In this study we report the synthesis of the 16alpha-(18)F and 16alpha-(19)F-analogs of the A-ring substituted estradiols in high yield via stereoselective opening of the intermediate 16beta,17beta-O-cyclic sulfones with [(18)F]F(-) or F(-) followed by deprotection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Estradiol / analogs & derivatives*
  • Estradiol / chemical synthesis
  • Estradiol / chemistry
  • Isotope Labeling / methods
  • Positron-Emission Tomography*
  • Radiopharmaceuticals / chemical synthesis*
  • Radiopharmaceuticals / chemistry*

Substances

  • Radiopharmaceuticals
  • Estradiol
  • 16-fluoroestradiol